NPPA issued a notification regarding the fixation of the retail price of Rosuvastatin Calcium IP eq to Rosuvastatin 10mg + Clopidogrel Bisulphate IP eq to Clopidogrel 75mg (as two light brown coloured film-coated tablets each containing Clopidogrel Tablets 37.5 mg)

Mar 01, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 01, 2024, issued a notification regarding the fixation of the retail price of Rosuvastatin Calcium IP eq to Rosuvastatin 10mg + Clopidogrel Bisulphate IP eq to Clopidogrel 75mg (as two light brown coloured film-coated tablets each containing Clopidogrel Tablets 37.5 mg).

The following has been stated: -

•Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq to Rosuvastatin 10mg + Clopidogrel Bisulphate IP eq to Clopidogrel 75mg (as two light brown coloured film-coated tablets each containing Clopidogrel Tablets 37.5 mg) the Retail Price (without local taxes) is 17.03.

[Notification No. 19(3860) /2024/DP/NPPA/Div.III/7636/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT